| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 04/23/2009 | CA2702950A1 Methods and compounds for modulating cannabinoid activity |
| 04/23/2009 | CA2702837A1 Piperidinyl and piperazinyl modulators of .gamma.-secretase |
| 04/23/2009 | CA2702563A1 Cgrp antagonists |
| 04/23/2009 | CA2702307A1 (r)-4-(heteroaryl) phenylethyl derivatives and pharmaceutical compositions containing them |
| 04/22/2009 | EP2050744A1 Quinazoline derivatives as angiogenesis inhibitors |
| 04/22/2009 | EP2049532A1 Cgrp receptor antagonists |
| 04/22/2009 | EP2049531A2 2-(heterocyclylbenzyl)pyridazinone derivatives |
| 04/22/2009 | EP2049529A1 Substituted diazepan orexin receptor antagonists |
| 04/22/2009 | EP2049528A2 Fungicide n-cycloalkyl-carboxamide derivatives |
| 04/22/2009 | EP2049521A2 Novel pyridazine derivatives |
| 04/22/2009 | EP2049520A2 Indole compounds |
| 04/22/2009 | EP2049517A1 Amino-piperidine derivatives as cetp inhibitors |
| 04/22/2009 | EP2049516A2 Pharmaceutical compounds |
| 04/22/2009 | EP2049506A2 Modulators of pharmacokinetic properties of therapeutics |
| 04/22/2009 | EP2049486A2 Piperidinyl derivatives as modulators of chemokine receptor activity |
| 04/22/2009 | EP2049481A2 Novel compounds as antagonists or inverse agonists for opioid receptors |
| 04/22/2009 | EP2049472A2 Cyclopropyl amine derivatives as histamin h3 receptor modulators |
| 04/22/2009 | EP1893608A4 Thiazolyl mglur5 antagonists and methods for their use |
| 04/22/2009 | EP1802572B1 Indol derivatives as inhibitors of soluble adenylyl cyclase |
| 04/22/2009 | EP1689391B1 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory airway diseases |
| 04/22/2009 | EP1673354B1 Arylindenopyridines and arylindenopyrimidines and their use as adenosine a2a receptor antagonists |
| 04/22/2009 | EP1387842B1 Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors |
| 04/22/2009 | CN101415704A 4-phenyl-thiazole-5-carboxylic acids and 4-phenyl-thiazole-5-carboxylic acid amides as PLK1 inhibitors |
| 04/22/2009 | CN101415702A Hetero compound |
| 04/22/2009 | CN101415700A Active ingredient combinations with insecticidal properties |
| 04/22/2009 | CN101415698A Fungicide n-cyclopropyl-sulfonylamide derivatives |
| 04/22/2009 | CN101415687A Binding inhibitor of sphingosine-1-phosphate |
| 04/22/2009 | CN101415674A Pyrrolidine derivatives as ERK inhibitors |
| 04/22/2009 | CN101415422A Anti-cancer pharmaceutical composition |
| 04/22/2009 | CN101412715A Aztreonam compound and preparation thereof |
| 04/22/2009 | CN101412714A Hydrate of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione maleic acid salt |
| 04/22/2009 | CN101412713A Hydrate of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione maleic acid salt |
| 04/22/2009 | CN101412712A Luminescent material naphtho oxazole derivative and preparation thereof |
| 04/22/2009 | CN100481571C Luminescent element material and luminescent element comprising the same |
| 04/22/2009 | CN100480389C Production of polyketides |
| 04/22/2009 | CN100480242C CDK-inhibitory pyrimidines, and production and use thereof as pharmaceutical agents |
| 04/22/2009 | CN100480225C Method for producing c1-c15 fragments of epothilones and the derivatives thereof |
| 04/21/2009 | US7521462 4-Amino-piperidine derivatives as monoamine uptake inhibitors |
| 04/21/2009 | US7521451 e.g. 5,6-dimethyl-3a,4,7,7a-tetrahydro-2-benzofuran-1,3-dione;intravenous, water-soluble compounds useful for manufacturing an anasthetic, sedative agents; side effect reduction |
| 04/21/2009 | US7521448 N-substituted benzimidazolyl c-Kit inhibitors |
| 04/21/2009 | US7521445 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
| 04/21/2009 | US7521396 processes for their preparation, and to their use as herbicides. |
| 04/21/2009 | CA2499329C Indole-3-carboxamides as glucokinase (gk) activators |
| 04/16/2009 | WO2009047558A1 Benzothiazoles as ghrelin receptor modulators |
| 04/16/2009 | WO2009047240A1 Indole derivatives useful as ppar activators |
| 04/16/2009 | WO2009047161A1 Chiral cis-imidazolines |
| 04/16/2009 | WO2009046842A2 Thiazol derivatives for treating cancer |
| 04/16/2009 | WO2009046841A2 Piperidine and piperazine derivatives for treating tumours |
| 04/16/2009 | WO2009046804A1 Imidazole derivatives |
| 04/16/2009 | WO2009046784A1 Pyridine derivatives useful as glucokinase activators |
| 04/16/2009 | WO2008108380A3 Pyrrole compounds |
| 04/16/2009 | WO2008103277A3 Nitrogen-containing heterocyclyl ketones and their use as c-met inhibitors |
| 04/16/2009 | WO2008054674A3 Antidiabetic bicyclic compounds |
| 04/16/2009 | WO2006047507A3 Phosphonate substituted kinase inhibitors |
| 04/16/2009 | US20090099243 Organic compounds |
| 04/16/2009 | US20090099209 Compounds Useful in Therapy |
| 04/16/2009 | US20090099207 Cyclic sulfones useful as BACE inhibitors |
| 04/16/2009 | US20090099200 Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 04/16/2009 | US20090099183 Pyrimidines and uses thereof |
| 04/16/2009 | US20090099163 Glucokinase activators |
| 04/16/2009 | US20090099160 4-(4-(Imidazol-4-Yl) Pyrimidin-2-Ylamino) Benzamides as CDK Inhibitors |
| 04/16/2009 | US20090099155 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 04/16/2009 | DE102007049157A1 New substituted 2,3-dihydro-(1,2,3)triazol-4-one compounds are hypoxia inducible factor-prolyl-4-hydroxylase inhibitor, useful for preparing medicament to treat and/or prevent e.g. cardiovascular diseases, inflammatory disease and anemia |
| 04/16/2009 | DE102007048447A1 New substituted dihydropyrazole-3-thione compounds are hypoxia inducible factor-prolyl-4-hydroxylase inhibitor, useful for preparing medicament to treat and/or prevent e.g. cardiovascular diseases, wound healing and anemia |
| 04/16/2009 | CA2702225A1 Diphenyl substituted cycloalkanes |
| 04/16/2009 | CA2702181A1 Benzothiazoles as ghrelin receptor modulators |
| 04/16/2009 | CA2701932A1 Chiral cis-imidazolines |
| 04/16/2009 | CA2701806A1 Pyridine derivatives useful as glucokinase activators |
| 04/16/2009 | CA2701568A1 Imidazole derivatives |
| 04/16/2009 | CA2701525A1 Thiazole derivatives |
| 04/16/2009 | CA2701519A1 Piperidine and piperazine derivatives |
| 04/16/2009 | CA2700049A1 Novel compounds as cannabinoid receptor ligands |
| 04/15/2009 | EP2048142A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof |
| 04/15/2009 | EP2048141A1 Optical pure dihydropyrimidine compounds, their uses in the manufacture of a medicamnent for the treatment or the prevention of virosis diseases |
| 04/15/2009 | EP2048137A1 Benzamide derivatives and their use as glucokinase activating agents. |
| 04/15/2009 | EP2046786A2 Polymorphic forms of ziprasidone sulfates |
| 04/15/2009 | EP2046765A1 Insecticidal compounds |
| 04/15/2009 | EP2046757A1 Caspase inhibitors based on pyridazinone scaffold |
| 04/15/2009 | EP2046753A2 Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 04/15/2009 | EP2046746A2 Chemical compounds |
| 04/15/2009 | EP2046739A1 Substituted aniline derivatives |
| 04/15/2009 | EP1812430B1 Substituted phenylaminothiazoles and use thereof |
| 04/15/2009 | EP1572686B1 Anthranilic acid amide derivatives and their pharmaceutical use |
| 04/15/2009 | EP1363635B1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 04/15/2009 | EP1244648B1 Chemokine receptor binding heterocyclic compounds |
| 04/15/2009 | CN101410395A Compound having thiadiazole ring structure substituted with pyridyl group and organic electroluminescent device |
| 04/15/2009 | CN101410394A HIV inhibiting 5-(hydroxymethylene and aminomethylene) substituted pyrimidines |
| 04/15/2009 | CN101410393A Novel heteroaryl substituted benzothiazoles |
| 04/15/2009 | CN101410390A Hydantoin compounds for the treatment of inflammatory disorders |
| 04/15/2009 | CN101410388A Compounds for the treatment of inflammatory disorders |
| 04/15/2009 | CN101410385A Benzothiazoles having histamine H3 receptor activity |
| 04/15/2009 | CN101410373A Bridged cyanine compounds and optical recording materials containing the same |
| 04/15/2009 | CN101410111A Useful combinations of monobactam antibiotics with beta-lactamase inhibitors |
| 04/15/2009 | CN101406469A Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| 04/15/2009 | CN100478331C Inhibitors of cathepsin s |
| 04/14/2009 | US7517994 Heterocyclic inhibitors of MEK and methods of use thereof |
| 04/14/2009 | US7517993 Pioglitazone hydrochloride |
| 04/14/2009 | US7517988 N-hydroxy-4-[2-(benzofuran-2-ylcarbonylamino)ethylsulfonyl]-benzamide; hepatitis C; inhibitors of histone deacetylase |
| 04/14/2009 | US7517903 1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indole-4-one (CBI) with incorporated alkylating domain; in vivo drug-cleavable substrate conjugates that are potent cytotoxins; antiproliferative, anticarcinogenic agent; leukemia; bone marrow and mucosal toxicity; chronic cardiac and neurological toxicity |
| 04/14/2009 | US7517902 1-[4-(3-amino-7-fluoro-1H-indazol-6-yl)phenyl]-3-(2-fluoro-5-trifluoromethyl-phenyl)urea; protein kinases (Vascular Endothelial Growth Factor Receptor 2 and Tie-2), inhibitor; anticarcinogenic, antiinflammatory agent; neovascularization, lung and breast cancer, rheumatoid arthritis |